Table 3 Altered immunoexpression of proteins per tumor category
Mucinous adenoma (n=32); percent (no.) | Uncertain malignant potential (n=23); percent (no.) | Mucinous adenocarcinoma (n=15); percent (no.) | |
|---|---|---|---|
β-Catenin, loss | 13 (4) | 9 (2) | 60 (9) |
CyclinD1, positive | 44 (14) | 44 (10) | 87 (13) |
Ki-67, high index | 31 (10) | 35 (8) | 67 (10) |
NF-κB, positive | 19 (6) | 52 (12) | 60 (9) |
VEGF, positive | 16 (5) | 83 (19) | 87 (13) |
E-cadherin, loss | 0 | 4 (1) | 47 (7) |
p53, overexpression | 6 (2) | 39 (8) | 40 (6) |
MUC2, positive | 9 (3) | 0 | 67 (10) |
MUC5AC, positive | 3 (1) | 0 | 40 (6) |
